Dr. Holt is a Radiation Oncologist with specialized training in SRS, SBRT, VMAT, High Dose Rate (HDR) Brachytherapy and Low Dose Radiation for Arthritis, Tendonitis, Bursitis, Plantar Fasciitis, and Dupuytrens Disease. In 2024 understand specialized training in Germany with world leaders in low dose radiation in treating benign conditions. He received the 2021 National Association of Community Cancer Centers (ACCC) Innovator of the Year Award and is the co-creator of a radiation-compatible video distraction system RadFlix used to reduce anxiety and anesthesia. Dr. Holt received training at Memorial Sloan Kettering; completed his residency at University of Colorado, where he served as Chief Resident; and graduated medical school from University of Pittsburgh. Currently employed with Utah Cancer Specialists.